A carregar...
A trial of brolitene in the treatment of spasticity.
A new anti-spasticity agent, brolitene, has been assessed in patients with spasticity of spinal or cerebral origin. Twenty-seven patients were entered in a double-blind cross-over trial lasting 6 weeks, using a fixed dose of six tablets (1200 mg brolitene) per day. Clinical assessment failed to show...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1976
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1428935/ https://ncbi.nlm.nih.gov/pubmed/788760 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|